Keating Investment Counselors Inc Bristol Myers Squibb CO Transaction History
Keating Investment Counselors Inc
- $230 Million
- Q2 2024
A detailed history of Keating Investment Counselors Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Keating Investment Counselors Inc holds 10,357 shares of BMY stock, worth $504,385. This represents 0.19% of its overall portfolio holdings.
Number of Shares
10,357
Previous 11,612
10.81%
Holding current value
$504,385
Previous $629,000
31.64%
% of portfolio
0.19%
Previous 0.26%
Shares
20 transactions
Others Institutions Holding BMY
# of Institutions
2,399Shares Held
1.5BCall Options Held
29.7MPut Options Held
32.2M-
Vanguard Group Inc Valley Forge, PA187MShares$9.09 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.73 Billion0.15% of portfolio
-
State Street Corp Boston, MA91.4MShares$4.45 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY74.6MShares$3.63 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA59.1MShares$2.88 Billion0.47% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $104B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...